Page last updated: 2024-10-22

alosetron and Chronic Illness

alosetron has been researched along with Chronic Illness in 2 studies

alosetron : A pyrido[4,3-b]indole compound having a 5-methyl-1H-imidazol-4-ylmethyl group at the 2-position.

Research Excerpts

ExcerptRelevanceReference
"To assess long-term safety and efficacy of alosetron in women with severe, chronic diarrhea-predominant IBS and in a subset having more frequent urgency (i."9.11Long-term safety and efficacy of alosetron in women with severe diarrhea-predominant irritable bowel syndrome. ( Ameen, VZ; Carter, EG; Chey, WD; Chey, WY; Dukes, GE; Heath, AT; Northcutt, A, 2004)
"To assess long-term safety and efficacy of alosetron in women with severe, chronic diarrhea-predominant IBS and in a subset having more frequent urgency (i."5.11Long-term safety and efficacy of alosetron in women with severe diarrhea-predominant irritable bowel syndrome. ( Ameen, VZ; Carter, EG; Chey, WD; Chey, WY; Dukes, GE; Heath, AT; Northcutt, A, 2004)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chey, WD1
Chey, WY1
Heath, AT1
Dukes, GE1
Carter, EG1
Northcutt, A1
Ameen, VZ1
Grundy, D1
McLean, P1
Stead, R1

Trials

1 trial available for alosetron and Chronic Illness

ArticleYear
Long-term safety and efficacy of alosetron in women with severe diarrhea-predominant irritable bowel syndrome.
    The American journal of gastroenterology, 2004, Volume: 99, Issue:11

    Topics: Abdominal Pain; Carbolines; Chronic Disease; Diarrhea; Double-Blind Method; Female; Gastrointestinal

2004

Other Studies

1 other study available for alosetron and Chronic Illness

ArticleYear
Impact of 5-HT3 receptor blockade on colonic haemodynamic responses to ischaemia and reperfusion in the rat.
    Neurogastroenterology and motility, 2007, Volume: 19, Issue:7

    Topics: Acute Disease; Animals; Carbolines; Chronic Disease; Colitis; Colon; Enzyme Inhibitors; Hyperemia; M

2007